Streetbeat News

Products Services

ZYXI

Zynex has received FDA clearance for its TensWave device, which is a significant milestone for the company. This approval could enhance Zynex's product offerings and potentially boost its market position.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 1:17 pm

FFIV

F5 Networks (NASDAQ:FFIV) has announced new leadership roles to enhance agility, productivity, and AI innovation. Tom Fountain is appointed as COO, Chad Whalen as CRO, and Kunal Anand as Chief Technology and AI Officer. These changes aim to drive operational efficiency and revenue growth.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 1:14 pm

BNAI

Brand Engagement Network (BEN) has entered into a contract with IntelliTek to expand access to AI solutions in healthcare across multiple regions, including the US. This partnership aims to enhance patient interaction through virtual assistants.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 1:13 pm

JAKK

NFLX

JAKKS Pacific's Disguise has extended its global rights to create costumes for Netflix's Stranger Things and Bridgerton for fall 2024. This includes a variety of costumes for both kids and adults, featuring popular characters from both series.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 1:12 pm

SPNT

SiriusPoint has announced a new partnership with travel insurtech company Gigasure. This collaboration aims to enhance SiriusPoint's offerings in the travel insurance sector.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 1:09 pm

GILD

Avenzo Therapeutics is collaborating with Gilead Sciences to evaluate a combination therapy of AVZO-021 and Trodelvy in HR+/HER2- metastatic breast cancer. Avenzo will sponsor the trial, while Gilead provides Trodelvy. The study is part of an ongoing Phase 1/2 trial, with combination cohorts starting in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 1:03 pm

LGVN

Longeveron has announced a Type C meeting with the FDA regarding the pathway to a Biological License Application (BLA) for Lomecel-B in treating Hypoplastic Left Heart Syndrome. The ongoing Phase 2b clinical trial, ELPIS II, is considered pivotal for potential full approval.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 1:03 pm

VLD

Velo3D has announced that the National Institute for Aviation Research has purchased a Sapphire 1MZ printer. This acquisition highlights the growing interest and application of Velo3D's advanced 3D printing technology in the aviation sector.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 1:02 pm

PEP

PZZA

Papa John's has renewed its contract with PepsiCo, making PepsiCo the exclusive beverage supplier for its North American operations for the next 10 years.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 1:01 pm

BITF

RIOT

Bitfarms Ltd (NASDAQ:BITF) shares are trading lower after the company reported a decrease in Bitcoin production for August compared to July and the previous year. Riot Platforms Inc (NASDAQ:RIOT) has proposed new board nominees for Bitfarms ahead of a special shareholder meeting.

Portfolio Pulse from Adam Eckert

September 03, 2024 | 12:59 pm